Studies related to Walking and L-Carnitine

Effect Of Propionyl-L-carnitine On Exercise Performance In Peripheral Arterial Disease

Effect None
Values Although the overall effect of propionyl l-carnitine on walking was not significant, four of the subjects did see considerable improvements, suggesting there could be "responders" and "non-responders" to the treatment.
Trial Design Randomized trial
Trial Length 2-4 Weeks
Number of Subjects 7
Sex n/a
Age Range 45-64, 65+
Notes for this study:
In this crossover study, individuals with intermittent claudication and peripheral artery disease underwent three different four-week conditions: a baseline condition followed by a condition where they supplemented 500 mg propionyl l-carnitine twice daily and a condition where they received a placebo.

Full details on all 4 studies are available to Examine members — try free for 14 days.

Already a member? Log in now to access.